The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes
In December 2020, the FDA granted emergency use approval for 2 separate mRNA vaccines to combat the COVID-19 pandemic. While many questions as to the long-term safety of the vaccine were raised, this was particularly acute for those patients trying to conceive and among those utilizing assisted repr...
Saved in:
Main Authors: | Adi Anis Heusler, Amir Weintraub, Diana Stein, Yael Melamed-Yekel, Sarit Kalfon, Yael Pasternak, David Kulak |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2541495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01) -
SARS-CoV-2 spike protein mutation variants: Recent advances in theragnostic and vaccines development
by: Jutishna Bora, et al.
Published: (2025-08-01) -
Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01) -
Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
by: F. D. Partey, et al.
Published: (2025-07-01) -
Evaluating vaccination dosing strategies for SARS-CoV-2 in patients at high-risk for allergic reactions: Insights from vaccination campaign
by: Stefania Nicola, MD, et al.
Published: (2025-08-01)